Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)
Clinical trial NCT05454410 · COMPLETED
Trial details
- NCT number
- NCT05454410
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2023-11-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.